What it takes to get Big Pharma Partners interested in a new technology

A new 90-minute recorded program, hosted by the Biotechnology Innovation Organization (BIO), offers insights from top Big Pharma professionals in search & evaluation licensing and venture investing about what it takes to get them interested in a new technology. (Video – May 26, 2022)

Big Pharma’s View of Emerging Tech for Partnership & Investment from BIO2022 on Vimeo.


Panelists share insights on: 

  • recent deals and why they got done
  • explore the challenges
  • share what makes a technology exciting and what tech/modalities and platforms are exploring
  • offer  advice for those biotechs that are ready for licensing or investment.

– Linda Pullan, PhD, Pullan Consulting

– Sasha Huhalov, Search & Evaluation, Oncology Lead, Takeda
– Jenny Laird, Vice-President, Neuroscience Search & Evaluation, Eli Lilly & Co.
– Chris Mortko, Head, Headquarters Search & Evaluation, Merck & Co.
– Gladys Nunez, Director, Amgen Ventures
– Jerry Shipps, Sr. Director, External Science & Innovation, Pfizer

Webinar sponsored by PSC Biotech and ShareVault.

Webinar recorded on May 26, 2022.

Posted in AZBio News, Resource Library.